questionsmedicales.fr
Thérapeutique
Hyperthermie provoquée
Hyperthermie provoquée : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hyperthermie
Diagnostic médical
Tests diagnostiques
Hyperthermie
Hyperthermie
Surveillance médicale
Symptômes
5
Troubles de la conscience
Hyperthermie
Éruption cutanée
Hyperthermie
Prévention
5
Surveillance
Hyperthermie
Alimentation
Hyperthermie
Traitements
5
Consultation médicale
Hyperthermie
Complications
5
Complications
Hyperthermie
Facteurs de risque
5
Facteurs de risque
Hyperthermie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperthermie provoquée : Questions médicales les plus fréquentes",
"headline": "Hyperthermie provoquée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperthermie provoquée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-20",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperthermie provoquée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Psammothérapie",
"alternateName": "Ammotherapy",
"url": "https://questionsmedicales.fr/mesh/D000646",
"about": {
"@type": "MedicalCondition",
"name": "Psammothérapie",
"code": {
"@type": "MedicalCode",
"code": "D000646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.020"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diathermie",
"alternateName": "Diathermy",
"url": "https://questionsmedicales.fr/mesh/D003972",
"about": {
"@type": "MedicalCondition",
"name": "Diathermie",
"code": {
"@type": "MedicalCode",
"code": "D003972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.280"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ultrasonothérapie",
"alternateName": "Ultrasonic Therapy",
"url": "https://questionsmedicales.fr/mesh/D014464",
"about": {
"@type": "MedicalCondition",
"name": "Ultrasonothérapie",
"code": {
"@type": "MedicalCode",
"code": "D014464",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.280.945"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chimiothérapie hyperthermique intrapéritonéale",
"alternateName": "Hyperthermic Intraperitoneal Chemotherapy",
"url": "https://questionsmedicales.fr/mesh/D000084262",
"about": {
"@type": "MedicalCondition",
"name": "Chimiothérapie hyperthermique intrapéritonéale",
"code": {
"@type": "MedicalCode",
"code": "D000084262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.370"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bain de vapeur",
"alternateName": "Steam Bath",
"url": "https://questionsmedicales.fr/mesh/D029002",
"about": {
"@type": "MedicalCondition",
"name": "Bain de vapeur",
"code": {
"@type": "MedicalCode",
"code": "D029002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.565.640"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperthermie provoquée",
"alternateName": "Hyperthermia, Induced",
"code": {
"@type": "MedicalCode",
"code": "D006979",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohammad-Amin Abdollahifar",
"url": "https://questionsmedicales.fr/author/Mohammad-Amin%20Abdollahifar",
"affiliation": {
"@type": "Organization",
"name": "Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: abdollahima@sbmu.ac.ir."
}
},
{
"@type": "Person",
"name": "Abbas Aliaghaei",
"url": "https://questionsmedicales.fr/author/Abbas%20Aliaghaei",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Jon E Sprague",
"url": "https://questionsmedicales.fr/author/Jon%20E%20Sprague",
"affiliation": {
"@type": "Organization",
"name": "The Ohio Attorney General's Center for the Future of Forensic Science, USA. Electronic address: jesprag@bgsu.edu."
}
},
{
"@type": "Person",
"name": "Amir Raoofi",
"url": "https://questionsmedicales.fr/author/Amir%20Raoofi",
"affiliation": {
"@type": "Organization",
"name": "Leishmaniasis Research Center, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran."
}
},
{
"@type": "Person",
"name": "Shabnam Abdi",
"url": "https://questionsmedicales.fr/author/Shabnam%20Abdi",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Methotrexate for CSPs.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37354647",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bpobgyn.2023.102364"
}
},
{
"@type": "ScholarlyArticle",
"name": "Medication error with methotrexate.",
"datePublished": "2024-03-21",
"url": "https://questionsmedicales.fr/article/38747669",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4045/tidsskr.23.0657"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methotrexate Polyglutamates Exposure - Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate.",
"datePublished": "2023-07-09",
"url": "https://questionsmedicales.fr/article/37313979",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cpt.2974"
}
},
{
"@type": "ScholarlyArticle",
"name": "Potential neurotoxicity associated with methotrexate.",
"datePublished": "2024-08-09",
"url": "https://questionsmedicales.fr/article/39122917",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-69263-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methotrexate-Induced Epidermal Necrosis.",
"datePublished": "2024-10-22",
"url": "https://questionsmedicales.fr/article/39433528",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hyperthermie provoquée",
"item": "https://questionsmedicales.fr/mesh/D006979"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperthermie provoquée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperthermie provoquée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperthermie provoquée",
"description": "Comment diagnostiquer l'hyperthermie provoquée ?\nQuels tests sont utilisés pour confirmer l'hyperthermie ?\nQuels signes cliniques indiquent une hyperthermie ?\nL'hyperthermie est-elle toujours dangereuse ?\nComment différencier l'hyperthermie de la fièvre ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Methotrexate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperthermie provoquée",
"description": "Quels sont les symptômes de l'hyperthermie provoquée ?\nL'hyperthermie provoquée cause-t-elle des douleurs ?\nPeut-on avoir des troubles de la conscience ?\nY a-t-il des signes cutanés associés ?\nL'hyperthermie provoquée affecte-t-elle la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Methotrexate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperthermie provoquée",
"description": "Comment prévenir l'hyperthermie provoquée ?\nLes vêtements influencent-ils l'hyperthermie ?\nFaut-il surveiller la température corporelle ?\nLes pauses sont-elles importantes ?\nL'alimentation joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Methotrexate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperthermie provoquée",
"description": "Comment traiter l'hyperthermie provoquée ?\nDes médicaments sont-ils nécessaires ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il consulter un médecin ?\nLe repos est-il recommandé ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Methotrexate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperthermie provoquée",
"description": "Quelles complications peuvent survenir ?\nL'hyperthermie peut-elle être mortelle ?\nQuels organes sont les plus affectés ?\nDes séquelles peuvent-elles persister ?\nComment éviter les complications graves ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Methotrexate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperthermie provoquée",
"description": "Qui est le plus à risque d'hyperthermie ?\nL'exercice augmente-t-il le risque ?\nLes médicaments influencent-ils le risque ?\nL'humidité joue-t-elle un rôle ?\nLe surpoids est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006979?mesh_terms=Methotrexate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperthermie provoquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique et la mesure de la température corporelle."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'hyperthermie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des évaluations physiologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une hyperthermie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une température élevée, des frissons et une confusion mentale."
}
},
{
"@type": "Question",
"name": "L'hyperthermie est-elle toujours dangereuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, elle peut être contrôlée, mais nécessite une surveillance."
}
},
{
"@type": "Question",
"name": "Comment différencier l'hyperthermie de la fièvre ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperthermie est causée par des facteurs externes, alors que la fièvre est une réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hyperthermie provoquée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges, des maux de tête et une confusion."
}
},
{
"@type": "Question",
"name": "L'hyperthermie provoquée cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des douleurs musculaires et des crampes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des troubles de la conscience ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la conscience peuvent survenir en cas d'hyperthermie sévère."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs ou des éruptions cutanées peuvent apparaître en cas d'hyperthermie."
}
},
{
"@type": "Question",
"name": "L'hyperthermie provoquée affecte-t-elle la respiration ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une respiration rapide et superficielle."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperthermie provoquée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les environnements chauds et hydratez-vous régulièrement lors d'activités physiques."
}
},
{
"@type": "Question",
"name": "Les vêtements influencent-ils l'hyperthermie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter des vêtements légers et respirants aide à prévenir l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller la température corporelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surveiller la température est essentiel lors d'activités à risque."
}
},
{
"@type": "Question",
"name": "Les pauses sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, prendre des pauses régulières lors d'activités physiques intenses est crucial."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée aide à maintenir une bonne régulation thermique."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hyperthermie provoquée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut le refroidissement du corps et l'hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être administrés pour soulager les symptômes associés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'hydratation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour prévenir des complications graves liées à l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Quand faut-il consulter un médecin ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent malgré le traitement."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est essentiel pour permettre au corps de récupérer."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des coups de chaleur, des défaillances organiques et des convulsions."
}
},
{
"@type": "Question",
"name": "L'hyperthermie peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperthermie sévère non traitée peut entraîner la mort."
}
},
{
"@type": "Question",
"name": "Quels organes sont les plus affectés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le cerveau, le cœur et les reins sont particulièrement vulnérables à l'hyperthermie."
}
},
{
"@type": "Question",
"name": "Des séquelles peuvent-elles persister ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles neurologiques peuvent persister après une hyperthermie sévère."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement rapide et approprié est essentiel pour éviter les complications graves."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'hyperthermie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les enfants et celles avec des maladies chroniques sont plus à risque."
}
},
{
"@type": "Question",
"name": "L'exercice augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice intense dans des environnements chauds augmente le risque d'hyperthermie."
}
},
{
"@type": "Question",
"name": "Les médicaments influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent altérer la régulation thermique et augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'humidité joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une humidité élevée augmente le risque d'hyperthermie en réduisant l'évaporation de la sueur."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le surpoids peut augmenter le risque d'hyperthermie en réduisant l'efficacité de la thermorégulation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: abdollahima@sbmu.ac.ir.
Publications dans "Hyperthermie provoquée" :
4 publications dans cette catégorie
Affiliations :
Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Hyperthermie provoquée" :
3 publications dans cette catégorie
Affiliations :
The Ohio Attorney General's Center for the Future of Forensic Science, USA. Electronic address: jesprag@bgsu.edu.
Publications dans "Hyperthermie provoquée" :
3 publications dans cette catégorie
Affiliations :
Leishmaniasis Research Center, Department of Anatomy, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Publications dans "Hyperthermie provoquée" :
3 publications dans cette catégorie
Affiliations :
Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, China.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Anatomy and Neurobiology, School of Basic Medical Sciences, Central South University, Changsha, China.
Hunan Key Laboratory of Ophthalmology, Changsha, China.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
School of Basic Medical Science, Xinjiang Medical University, Urumqi, China.
Department of Forensic Science, School of Basic Medical Science, Central South University, Changsha, China.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Ohio Attorney General's Center for the Future of Forensic Science, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Department of Biological Sciences, Bowling Green State University, Bowling Green, OH, 43403, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Department of Biological Sciences, Bowling Green State University, Bowling Green, OH, 43403, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Department of Biological Sciences, Bowling Green State University, Bowling Green, Ohio, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
The Department of Biological Sciences, Bowling Green State University, Bowling Green, Ohio, USA.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Jichi Medical University, Japan. Electronic address: okada-tsuyoshi@clear.ocn.ne.jp.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Jichi Medical University, Japan; Cocoro Care Center, Jichi Medical University, Japan.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Jichi Medical University, Japan.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Universidad de Castilla-La Mancha. Department of Inorganic, Organic Chemistry and Biochemistry. Faculty of Chemical and Technological Sciences. School of Medicine of Ciudad Real. Regional Centre of Biomedical Research (CRIB), Avenida Camilo José Cela, 10, 13071 Ciudad Real, Spain.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Universidad de Castilla-La Mancha. Department of Inorganic, Organic Chemistry and Biochemistry. Faculty of Chemical and Technological Sciences. School of Medicine of Ciudad Real. Regional Centre of Biomedical Research (CRIB), Avenida Camilo José Cela, 10, 13071 Ciudad Real, Spain. Electronic address: Davidagustin.leon@uclm.es.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Universidad de Castilla-La Mancha. Department of Inorganic, Organic Chemistry and Biochemistry. Faculty of Chemical and Technological Sciences. School of Medicine of Ciudad Real. Regional Centre of Biomedical Research (CRIB), Avenida Camilo José Cela, 10, 13071 Ciudad Real, Spain.
Publications dans "Hyperthermie provoquée" :
2 publications dans cette catégorie
Affiliations :
Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Hyperthermie provoquée" :
Expectant management of a cesarean scar pregnancy (CSP) is associated with a high risk of severe maternal morbidity. Therefore, most experts recommend immediate termination after the diagnosis of a CS...
A woman in her seventies presented to the accident and emergency department (A&E) with shortness of breath that had increased over a period of three weeks. She had a history of COPD, hypertension and ...
The patient arrived with stable vital signs, including 94 % oxygen saturation and a respiratory rate of 20 breaths/min. She had been taking 2.5 mg of methotrexate daily for the past three weeks instea...
Considering her medical history and exclusion of other differential diagnoses, methotrexate toxicity was suspected. The patient was admitted to the hospital and intravenous folinic acid was initiated ...
Methotrexate polyglutamates (MTX-PG) concentrations in red blood cells (RBCs) have been suggested as a biomarker of response in patients with rheumatoid arthritis (RA) receiving low-dose MTX therapy. ...
This study aimed to elucidate the incidence and characteristics of neurotoxicity in patients receiving methotrexate (MTX) treatment. A retrospective analysis was performed using data from the electron...
A 79-year-old woman with psoriasis presented to the emergency department with new-onset eruptions on the trunk, extremities, and oral mucosa for 8-9 days. For psoriasis, she had been taking 15 mg of m...
Leptomeningeal spread of cancer is rare, difficult to both diagnostically confirm and treat, and associated with a poor prognosis. The blood-brain barrier largely prevents sufficient penetration of sy...
Low-dose weekly methotrexate (MTX) is the mainstay of treatment in juvenile idiopathic arthritis. Unfortunately, a substantial part of patients has insufficient efficacy of MTX. A potential cause of t...
This was a retrospective, observational study using plasma samples from juvenile idiopathic arthritis patients. An ultrasensitive liquid chromatography-tandem mass spectrometry method was developed fo...
Plasma samples of 43 patients with juvenile idiopathic arthritis were analysed. Adherence to MTX in this population was 88% shortly after initiation of MTX therapy and decreased to 77% after one year ...
Quantification of MTX in plasma is a feasible and objective method to assess adherence in patients using low-dose weekly MTX. In clinical practice, the use of this method could be a helpful tool for p...
In immune-mediated inflammatory diseases (IMIDs), early symptom control is a key therapeutic goal. Methotrexate (MTX) is the first-line treatment across IMIDs. However, MTX is underutilized and subopt...
Studies analysing MTX-PG in relation to disease activity and/or toxicity were included for inflammatory arthritis (rheumatoid [RA] and juvenile idiopathic arthritis [JIA]), inflammatory bowel disease ...
Twenty-five studies were included. In RA and JIA, higher MTX-PG was significantly associated with lower disease activity at 3 months (β: -0.002; 95% confidence interval [CI]: -0.004 to -0.001) and aft...
We showed that higher concentrations of erythrocyte MTX-PG were associated with lower disease activity in RA, JIA and psoriasis. These findings are an important step towards implementation of TDM for ...
Methotrexate (MTX) is the most widely used disease-modifying anti-rheumatic drug (DMARD) for rheumatoid arthritis (RA). Many studies have attempted to understand the genetic risk factors that affect t...
Methotrexate (MTX), a folate antagonist, is often used as second-line treatment in patients with sarcoidosis. Effectiveness of MTX has large inter-patient variability and at present therapeutic drug m...
We retrospectively included patients with sarcoidosis that had started on MTX therapy and from whom blood samples and FDG-PET/CT were available 3 and 6-12 months after MTX initiation, respectively. FD...
We included 42 sarcoidosis patients treated with MTX (15 mg/week); 31 with cardiac sarcoidosis and 11 with pulmonary sarcoidosis. In MTXPG...
These results suggest a relation between MTXPG...